RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/32044355http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/32044355http://www.w3.org/2000/01/rdf-schema#comment"The human cytochrome P450 enzyme CYP4Z1 remains an understudied enzyme despite its association with poor prognosis and overexpression in breast cancer. Hence, CYP4Z1 has previously been suggested as an anti-breast cancer target. In the present study we employed extended mutation analysis to increase our understanding of the substrate binding mode of this enzyme. In a combined in vitro and in silico approach we show for the first time that residue Arg487 plays an important role in substrate recognition and binding of CYP4Z1. Using a large array of recombinant CYP4Z1 mutants we show that, apart from Asn381, all other postulated binding residues only play an auxiliary role in substrate recognition and binding. Different substrate interaction motifs were identified via dynamic pharmacophores (dynophores) and their impact on catalytically competent substrate binding was classified. These new insights on the substrate recognition and binding mode represent an important step towards the rational design of CYP4Z1 prodrugs and guide further investigations into the so far poorly understood physiological role of CYP4Z1."xsd:string
http://purl.uniprot.org/citations/32044355http://purl.org/dc/terms/identifier"doi:10.1016/j.bcp.2020.113850"xsd:string
http://purl.uniprot.org/citations/32044355http://purl.uniprot.org/core/author"Yan Q."xsd:string
http://purl.uniprot.org/citations/32044355http://purl.uniprot.org/core/author"Du W."xsd:string
http://purl.uniprot.org/citations/32044355http://purl.uniprot.org/core/author"Wolber G."xsd:string
http://purl.uniprot.org/citations/32044355http://purl.uniprot.org/core/author"Bureik M."xsd:string
http://purl.uniprot.org/citations/32044355http://purl.uniprot.org/core/author"Sorensen E.J."xsd:string
http://purl.uniprot.org/citations/32044355http://purl.uniprot.org/core/author"Machalz D."xsd:string
http://purl.uniprot.org/citations/32044355http://purl.uniprot.org/core/date"2020"xsd:gYear
http://purl.uniprot.org/citations/32044355http://purl.uniprot.org/core/name"Biochem Pharmacol"xsd:string
http://purl.uniprot.org/citations/32044355http://purl.uniprot.org/core/pages"113850"xsd:string
http://purl.uniprot.org/citations/32044355http://purl.uniprot.org/core/title"Importance of asparagine-381 and arginine-487 for substrate recognition in CYP4Z1."xsd:string
http://purl.uniprot.org/citations/32044355http://purl.uniprot.org/core/volume"174"xsd:string
http://purl.uniprot.org/citations/32044355http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/32044355
http://purl.uniprot.org/citations/32044355http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/32044355
http://purl.uniprot.org/uniprot/#_Q86W10-mappedCitation-32044355http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/32044355
http://purl.uniprot.org/uniprot/Q86W10http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/32044355